Loading…

Comparison of MY09/11 consensus PCR and type-specific PCR5 in the detection of oncogenic HPV types

The causal relationship between persistent infection with high-risk HPV and cervical cancer has resulted in the development of HPV DNA detection systems. The widely used MY09/11 consensus PCR targets a 450bp conserved sequence in the HPV L1 gene, and can therefore amplify a broad spectrum of HPV typ...

Full description

Saved in:
Bibliographic Details
Published in:Journal of cellular and molecular medicine 2007-07, Vol.11 (4), p.881
Main Authors: Depuydt, C E, Boulet, G A V, Horvath, C A J, Benoy, I H, Vereecken, A J, Bogers, J J
Format: Article
Language:English
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites
container_end_page
container_issue 4
container_start_page 881
container_title Journal of cellular and molecular medicine
container_volume 11
creator Depuydt, C E
Boulet, G A V
Horvath, C A J
Benoy, I H
Vereecken, A J
Bogers, J J
description The causal relationship between persistent infection with high-risk HPV and cervical cancer has resulted in the development of HPV DNA detection systems. The widely used MY09/11 consensus PCR targets a 450bp conserved sequence in the HPV L1 gene, and can therefore amplify a broad spectrum of HPV types. However, limitations of these consensus primers are evident, particularly in regard to the variability in detection sensitivity among different HPV types. This study compared MY09/11 PCR with type-specific PCRs in the detection of oncogenic HPV types. The study population comprised 15, 774 patients. Consensus PCR failed to detect 522 (10.9%) HPV infections indicated by type-specific PCRs. A significant correlation between failure of consensus PCR and HPV type was found. HPV types 51, 68 and 45 were missed most frequently. The clinical relevance of the HPV infections missed by MY09/11 PCR was reflected in the fraction of cases with cytological abnormalities and in follow-up, showing 104 (25.4%) CIN2+ cases. The MY09/11 false negativity could be the result of poor sensitivity, mismatch of MY09/11 primers or disruption of L1 target by HPV integration or DNA degradation. Furthermore, MY09/11 PCR lacked specificity for oncogenic HPVs. Diagnostic accuracy of the PCR systems, in terms of sensitivity (MY09/11 PCR: 87.9%; type-specific PCRs: 98.3%) and specificity (MY09/11 PCR: 38.7%; type-specific PCRs: 76.14%), and predictive values for histologically confirmed CIN2+, suggest that type-specific PCRs could be used in a clinical setting as a reliable screening tool. [PUBLICATION ABSTRACT]
format article
fullrecord <record><control><sourceid>proquest</sourceid><recordid>TN_cdi_proquest_journals_217171170</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1508254331</sourcerecordid><originalsourceid>FETCH-proquest_journals_2171711703</originalsourceid><addsrcrecordid>eNqNjM0KgkAUhWdRkP28w6W95DiYupbCTSARQSux8VojNTN5x0Vvn_08QJzFgXO-c0bM41ES-jwRyYRNidogEGsuUo-dM3O3VafIaDAN7E5BuuIcpNGEmnqCIttDpWtwT4s-WZSqUfKdRqA0uCtCjQ6lU98Do6W5oB6QvDh-RjRn46a6ES5-PmPL7eaQ5b7tzKNHcmVr-k4PVRnyeBCPA_EX9AIvjEJJ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>217171170</pqid></control><display><type>article</type><title>Comparison of MY09/11 consensus PCR and type-specific PCR5 in the detection of oncogenic HPV types</title><source>Publicly Available Content Database</source><source>Wiley Open Access Journals</source><source>PubMed Central</source><creator>Depuydt, C E ; Boulet, G A V ; Horvath, C A J ; Benoy, I H ; Vereecken, A J ; Bogers, J J</creator><creatorcontrib>Depuydt, C E ; Boulet, G A V ; Horvath, C A J ; Benoy, I H ; Vereecken, A J ; Bogers, J J</creatorcontrib><description>The causal relationship between persistent infection with high-risk HPV and cervical cancer has resulted in the development of HPV DNA detection systems. The widely used MY09/11 consensus PCR targets a 450bp conserved sequence in the HPV L1 gene, and can therefore amplify a broad spectrum of HPV types. However, limitations of these consensus primers are evident, particularly in regard to the variability in detection sensitivity among different HPV types. This study compared MY09/11 PCR with type-specific PCRs in the detection of oncogenic HPV types. The study population comprised 15, 774 patients. Consensus PCR failed to detect 522 (10.9%) HPV infections indicated by type-specific PCRs. A significant correlation between failure of consensus PCR and HPV type was found. HPV types 51, 68 and 45 were missed most frequently. The clinical relevance of the HPV infections missed by MY09/11 PCR was reflected in the fraction of cases with cytological abnormalities and in follow-up, showing 104 (25.4%) CIN2+ cases. The MY09/11 false negativity could be the result of poor sensitivity, mismatch of MY09/11 primers or disruption of L1 target by HPV integration or DNA degradation. Furthermore, MY09/11 PCR lacked specificity for oncogenic HPVs. Diagnostic accuracy of the PCR systems, in terms of sensitivity (MY09/11 PCR: 87.9%; type-specific PCRs: 98.3%) and specificity (MY09/11 PCR: 38.7%; type-specific PCRs: 76.14%), and predictive values for histologically confirmed CIN2+, suggest that type-specific PCRs could be used in a clinical setting as a reliable screening tool. [PUBLICATION ABSTRACT]</description><identifier>ISSN: 1582-1838</identifier><language>eng</language><publisher>Bucharest: Blackwell Publishing Ltd</publisher><subject>Causality ; Cervical cancer ; Comparative analysis ; Genes ; Human papillomavirus ; Medical screening ; Molecular biology</subject><ispartof>Journal of cellular and molecular medicine, 2007-07, Vol.11 (4), p.881</ispartof><rights>Copyright Blackwell Publishing Ltd. Jul/Aug 2007</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,37011</link.rule.ids></links><search><creatorcontrib>Depuydt, C E</creatorcontrib><creatorcontrib>Boulet, G A V</creatorcontrib><creatorcontrib>Horvath, C A J</creatorcontrib><creatorcontrib>Benoy, I H</creatorcontrib><creatorcontrib>Vereecken, A J</creatorcontrib><creatorcontrib>Bogers, J J</creatorcontrib><title>Comparison of MY09/11 consensus PCR and type-specific PCR5 in the detection of oncogenic HPV types</title><title>Journal of cellular and molecular medicine</title><description>The causal relationship between persistent infection with high-risk HPV and cervical cancer has resulted in the development of HPV DNA detection systems. The widely used MY09/11 consensus PCR targets a 450bp conserved sequence in the HPV L1 gene, and can therefore amplify a broad spectrum of HPV types. However, limitations of these consensus primers are evident, particularly in regard to the variability in detection sensitivity among different HPV types. This study compared MY09/11 PCR with type-specific PCRs in the detection of oncogenic HPV types. The study population comprised 15, 774 patients. Consensus PCR failed to detect 522 (10.9%) HPV infections indicated by type-specific PCRs. A significant correlation between failure of consensus PCR and HPV type was found. HPV types 51, 68 and 45 were missed most frequently. The clinical relevance of the HPV infections missed by MY09/11 PCR was reflected in the fraction of cases with cytological abnormalities and in follow-up, showing 104 (25.4%) CIN2+ cases. The MY09/11 false negativity could be the result of poor sensitivity, mismatch of MY09/11 primers or disruption of L1 target by HPV integration or DNA degradation. Furthermore, MY09/11 PCR lacked specificity for oncogenic HPVs. Diagnostic accuracy of the PCR systems, in terms of sensitivity (MY09/11 PCR: 87.9%; type-specific PCRs: 98.3%) and specificity (MY09/11 PCR: 38.7%; type-specific PCRs: 76.14%), and predictive values for histologically confirmed CIN2+, suggest that type-specific PCRs could be used in a clinical setting as a reliable screening tool. [PUBLICATION ABSTRACT]</description><subject>Causality</subject><subject>Cervical cancer</subject><subject>Comparative analysis</subject><subject>Genes</subject><subject>Human papillomavirus</subject><subject>Medical screening</subject><subject>Molecular biology</subject><issn>1582-1838</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2007</creationdate><recordtype>article</recordtype><recordid>eNqNjM0KgkAUhWdRkP28w6W95DiYupbCTSARQSux8VojNTN5x0Vvn_08QJzFgXO-c0bM41ES-jwRyYRNidogEGsuUo-dM3O3VafIaDAN7E5BuuIcpNGEmnqCIttDpWtwT4s-WZSqUfKdRqA0uCtCjQ6lU98Do6W5oB6QvDh-RjRn46a6ES5-PmPL7eaQ5b7tzKNHcmVr-k4PVRnyeBCPA_EX9AIvjEJJ</recordid><startdate>20070701</startdate><enddate>20070701</enddate><creator>Depuydt, C E</creator><creator>Boulet, G A V</creator><creator>Horvath, C A J</creator><creator>Benoy, I H</creator><creator>Vereecken, A J</creator><creator>Bogers, J J</creator><general>Blackwell Publishing Ltd</general><scope>K9.</scope></search><sort><creationdate>20070701</creationdate><title>Comparison of MY09/11 consensus PCR and type-specific PCR5 in the detection of oncogenic HPV types</title><author>Depuydt, C E ; Boulet, G A V ; Horvath, C A J ; Benoy, I H ; Vereecken, A J ; Bogers, J J</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-proquest_journals_2171711703</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2007</creationdate><topic>Causality</topic><topic>Cervical cancer</topic><topic>Comparative analysis</topic><topic>Genes</topic><topic>Human papillomavirus</topic><topic>Medical screening</topic><topic>Molecular biology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Depuydt, C E</creatorcontrib><creatorcontrib>Boulet, G A V</creatorcontrib><creatorcontrib>Horvath, C A J</creatorcontrib><creatorcontrib>Benoy, I H</creatorcontrib><creatorcontrib>Vereecken, A J</creatorcontrib><creatorcontrib>Bogers, J J</creatorcontrib><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><jtitle>Journal of cellular and molecular medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Depuydt, C E</au><au>Boulet, G A V</au><au>Horvath, C A J</au><au>Benoy, I H</au><au>Vereecken, A J</au><au>Bogers, J J</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Comparison of MY09/11 consensus PCR and type-specific PCR5 in the detection of oncogenic HPV types</atitle><jtitle>Journal of cellular and molecular medicine</jtitle><date>2007-07-01</date><risdate>2007</risdate><volume>11</volume><issue>4</issue><spage>881</spage><pages>881-</pages><issn>1582-1838</issn><abstract>The causal relationship between persistent infection with high-risk HPV and cervical cancer has resulted in the development of HPV DNA detection systems. The widely used MY09/11 consensus PCR targets a 450bp conserved sequence in the HPV L1 gene, and can therefore amplify a broad spectrum of HPV types. However, limitations of these consensus primers are evident, particularly in regard to the variability in detection sensitivity among different HPV types. This study compared MY09/11 PCR with type-specific PCRs in the detection of oncogenic HPV types. The study population comprised 15, 774 patients. Consensus PCR failed to detect 522 (10.9%) HPV infections indicated by type-specific PCRs. A significant correlation between failure of consensus PCR and HPV type was found. HPV types 51, 68 and 45 were missed most frequently. The clinical relevance of the HPV infections missed by MY09/11 PCR was reflected in the fraction of cases with cytological abnormalities and in follow-up, showing 104 (25.4%) CIN2+ cases. The MY09/11 false negativity could be the result of poor sensitivity, mismatch of MY09/11 primers or disruption of L1 target by HPV integration or DNA degradation. Furthermore, MY09/11 PCR lacked specificity for oncogenic HPVs. Diagnostic accuracy of the PCR systems, in terms of sensitivity (MY09/11 PCR: 87.9%; type-specific PCRs: 98.3%) and specificity (MY09/11 PCR: 38.7%; type-specific PCRs: 76.14%), and predictive values for histologically confirmed CIN2+, suggest that type-specific PCRs could be used in a clinical setting as a reliable screening tool. [PUBLICATION ABSTRACT]</abstract><cop>Bucharest</cop><pub>Blackwell Publishing Ltd</pub></addata></record>
fulltext fulltext
identifier ISSN: 1582-1838
ispartof Journal of cellular and molecular medicine, 2007-07, Vol.11 (4), p.881
issn 1582-1838
language eng
recordid cdi_proquest_journals_217171170
source Publicly Available Content Database; Wiley Open Access Journals; PubMed Central
subjects Causality
Cervical cancer
Comparative analysis
Genes
Human papillomavirus
Medical screening
Molecular biology
title Comparison of MY09/11 consensus PCR and type-specific PCR5 in the detection of oncogenic HPV types
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-12T19%3A20%3A20IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Comparison%20of%20MY09/11%20consensus%20PCR%20and%20type-specific%20PCR5%20in%20the%20detection%20of%20oncogenic%20HPV%20types&rft.jtitle=Journal%20of%20cellular%20and%20molecular%20medicine&rft.au=Depuydt,%20C%20E&rft.date=2007-07-01&rft.volume=11&rft.issue=4&rft.spage=881&rft.pages=881-&rft.issn=1582-1838&rft_id=info:doi/&rft_dat=%3Cproquest%3E1508254331%3C/proquest%3E%3Cgrp_id%3Ecdi_FETCH-proquest_journals_2171711703%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=217171170&rft_id=info:pmid/&rfr_iscdi=true